Funding This work was supported by Business Finland grant #1498/31/2019, Sigrid Juselius Foundation and the Academy of Finland (for A.S.) Conflict of interest The NADMED redox profiling method is a subject of patent application WO 2022/008802 (Euro and Suomalainen-Wartiovaara, 2022, 2023a, 2023b
I generally recommend starting at 0.25 mg for the first week regardless of injury severity
Officially, even with the committees recommendation, the peptides have not moved out of the regulatory gray area, but will do so if the FDA accepts the committees recommendation
Gupta et al., 2023), also known as the photosensory core module
Bottom line: Route of administration and regulatory status matter here more than usualand most online discussions gloss over both